Cost effectiveness of MRA’s in Healthcare Reform.

MRI’s have been looked at as overused and overutilized in many circles recently. I firmly disagree, I feel there are a few people that have abused the system but most exams are needed. We need to consider what information we get from the MRI/MRA Scans that we do. This Information is essential in the treatment of patients.

These are just a few things …..

Age of strokes (MRI Brains)

Infection of soft tissue.(MRI’s)

Osteomyelitis, MRSA

Detail of vascular anatomy.(MRA’s)

When a patient has an MRA of the Chest, Carotid, Runoff, or Abdomen, we are able to see in detail the anatomy of their arteries. In some cases we can see veins using delayed scanning. This may be essential information before proceeding with a coronary arteriogram or peripheral arteriogram. It may save the interventional doctor time by already having a map of the blood vessels before starting the procedure. Placing Stents, Angioplasty, and using new technologies like the Silverhawk arthrectomy catheter can take time.

Having the MRA done first gives you a head start going into the case already knowing what the vessels look like and where the stenosis is. The Doctors can already have an Idea of what type of intervention will best suit the patient due to the site of the disease. Having the MRA first is an advantage I would not want to be without. In the cases of Emergency Cardiac Cath it may be best not to do the MRA’s, to expedite care. For all non emergent procedures MRA’s can be beneficial.

In this Image below It is helpful to know ahead of time there is stenosis in the left leg. This may or may not play a deciding factor on where the initial groin stick will be.


Knowing there is an aneurysm may also be important to the Interventional Doctor.

There is a definite improvement in the MRI technology. “Three-dimensional (3D) gadolinium-enhanced magnetic resonance (MR) angiography has become very popular in the few years since its inception. A technique that combines speed, superb contrast, and relative simplicity, 3D gadolinium-enhanced MR angiography has been applied to virtually all regions of the body from the extremities to the brain.” (James F. Glockner, MD, PhD). We can now cost effectively diagnose most patients without needing to do a conventional angiogram. If a conventional angiogram is needed after the MRA, to place a stent or fix a stenotic lesion, then the Interventional Doctor has the original MRA to use as a guide.

Three-dimensional Gadolinium-enhanced MR Angiography: Applications for Abdominal Imaging


Posted in Uncategorized.

Toshiba 3T Vantage approved by FDA

Anyone using Toshiba magnets please comment about your experience. Good or bad. Thank you! I think this new magnet will be a nice one!!

Vantage Titan 3T

Titan 3T sets new standards in Comfort, Imaging and Productivity
Experience 3T like never before!
With Toshiba’s Titan series, you provide unsurpassed comfort to your patient, combining a short 1.6 meter magnet with a large 71 cm opening, reducing patient anxiety and allowing 80% of the body to be scanned feet first.

The widest…
What do 71 cm bring in practice?
More comfort for your patients
Helps against claustrophobia
More space to fit patients of all sizes
Reduce stress and anxienty
Easy check-on and access-to your patient
Ideal for pediatrics and geriatrics
Ideal for breast imaging
The quietest…
Acoustic noise is an important source of problems on conventional MR systems. It makes communication with the patient difficult and causes the patient discomfort. It can induce transient or permanent hearing disturbance and also poses a hazard for pediatric patients who need sedation.

Toshiba’s unique PianissimoTM technology has been further improved
and applied to provide the quietest 3T system available.
Read more about PianissimoTM

Magnetic Field Homogeneity: B0
While conventional MR systems offer a spherical homogeneous are centered at the iso-center of the scanner, a cylinder corresponds better to the form of the human body. With conform technology, Titan 3T offers a 50 x 50 x 45 cm cylindrical homogeneous Field Of View.

RF Field Homogeneity: B1
Titan 3T uses optimized amplitude and phase transmission called “Multi Phase Transmit”. It has the functionality of a Multi-channel Transmit Array, using multiple ports and multiple phases for optimal B1 homogeneity. It removes shading artifacts, improves SAR and reduces scan times by up to 40%.

Exceptional Contrast Resolution
With Conform and Multi-Phase Transmit technologies, abdominal and pelvic imaging are no challenge on Titan 3T. No more shading on your T2-weighted (fast) spin echo images. No more uneven fat suppression on your images. You can use SSFP from head to toe!

Image on the right:
T2-W FSE (0.5×0.5×2.5mm)

Atlas matrix coil system
In conventional MR systems, the organ specific coils require frequent coil exchange. The heavy weight of most coils makes the task tedious for the operators and the time devoted to this operation is wasted. With Atlas, coil exchange is dramaitically recuced and the few times it is required, the light weight of the coils makes it a fast and easy operation. This way, the workflow is significantly increased.
Read more about Atlas







Add gadolinium contrast to Flair Images for better Scans.

Contrast FLAIR tops FLAIR and contrast T1-weighted images

T1, T2 synergies increase sensitivity for detection of subtle abnormalities, especially in cortical lesions

By WILLIAM G. BRADLEY JR., M.D., PH.D., FACR | October 14, 2010
DR. BRADLEY is chair of radiology at the University of California, San Diego in the U.S.


When considering which is the most sensitive MRI technique for detecting disease in the brain, the choice is usually between contrast-enhanced T1-weighted imaging and T2-weighted fluid-attenuated inversion recovery (FLAIR) imaging. Twelve years ago, however, we found that contrast-enhanced FLAIR was actually more sensitive than either,1 particularly for subtle cortical lesions (Figure 1). This sensitivity is likely due to the combination of T2 prolongation, the usual mechanism for parenchymal hyperintensity on FLAIR images, and T1 shortening from the gadolinium chelate. While we normally think of T2 prolongation as the only mechanism for increasing signal intensity on T2-weighted FLAIR images, T1 shortening can also increase signal if it hasn’t maxed out yet. Since T2 prolongation and T1 shortening are synergistic, contrast-enhanced FLAIR is more sensitive for subtle abnormalities than either FLAIR alone or postcontrast T1-weighted imaging alone.

Figure 1

The greatest advantage of contrast-enhanced FLAIR seems to be for detecting subtle cortical abnormalities such as leptomeningeal carcinomatosis (Figure 1), where there is no mass effect. However, it also has an advantage when compared with conventional FLAIR or T2-weighted imaging for deep lesions (Figure 2), where the contrast between the enhancing lesion and the surrounding vasogenic edema is greater than with conventional techniques, and produces very remarkable images.

A reason contrast-enhanced FLAIR is especially sensitive for subtle cortical abnormalities may be that a small amount of gadolinium leaks into the adjacent sulcus. While this may not produce enough T1 shortening to be seen on a T1-weighted image, it may shorten the T1 of cerebrospinal fluid so that it is no longer nulled by the initial 180o pulse in the inversion recovery FLAIR technique.

Figure 2Contrast-enhanced FLAIR need not take longer than a conventional contrast-enhanced brain study. Since unenhanced FLAIR is usually a part of an MR brain exam, we merely acquire it after contrast is given, rather than before, as is usually done. In the beginning we would acquire T1-weighted images with and without contrast as well as FLAIRs with and without contrast. However, with time, we found we did not need the precontrast FLAIR. Comparing T1-weighted images pre- and postcontrast demonstrated enhancement, and any additional signal on the contrast-enhanced FLAIR we found to be due to T2 prolongation. Since most enhancing lesions generally also produce vasogenic edema, which prolongs T2, the two contrast mechanisms are synergistic.

When reading out brain studies performed with contrast enhancement, I usually read the contrast-enhanced FLAIRs first. If they are normal, it is unlikely that the enhanced T1-weighted images or the unenhanced FLAIRs will add anything. If they are abnormal, the pre- and post–T1-weighted images can sort out whether the brightness on the contrast-enhanced FLAIRs is due more to contrast enhancement or T2 prolongation.



Posted in Uncategorized.

MRI and Von Hippel-Lindau Disease

Von Hippel Lindau disease (VHL) is an inherited mutation of the VHL gene, which causes tumors to form in areas of the body that contain large numbers of blood vessels. One in every 32,000 children born in the U.S. is affected by VHL.

Von Hippel Lindau (VHL) disease was first described at the beginning of the 20thcentury by Eugen von Hippel and Arvid Lindau. A mutation of the VHL gene can affect several organs of the body, and can be expressed differently in every patient and every family. The most common manifestations of VHL include cysts and tumors of the retina, brain, spinal cord, kidney, pancreas and inner ear.

Patients with VHL can present with cerebellar hemangioblastomas, retinal hemangioblastomas, pheochromocytomas, kidney cancer, pancreatic cysts and pancreatic neuroendocrine tumors.

The University of Texas: MD Anderson Cancer Center


MD Anderson Resources

Call askMDAnderson



Imaging in Von Hippel-Lindau Syndrome

  • Author: Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR; Chief Editor: James G Smirniotopoulos, MD   more


Grouped as a hereditary phakomatosis, von Hippel-Lindau syndrome (VHL) is an autosomal dominant, inherited, neurocutaneous dysplasia complex with an 80-100% penetrance and variable delayed expressivity. Sex distributions are equal, and 20% of cases are familial. Images of VHL are shown below,

von Hippel-Lindau syndrome. Transaxial nonenhancedvon Hippel-Lindau syndrome. Transaxial nonenhanced and contrast-enhanced CT scans through the cerebellum in a 34-year-old patient with a family history of VHL. Scans show a midline cerebellar cystic lesion with an enhancing nodule (arrow) due to cerebellar hemangioblastoma.von Hippel-Lindau syndrome. T1-weighted transaxialvon Hippel-Lindau syndrome. T1-weighted transaxial gadolinium-enhanced MRIs of the same patient as in the previous image show a well-defined hypervascular enhancing mass.von Hippel-Lindau syndrome. Coronal vertebral angivon Hippel-Lindau syndrome. Coronal vertebral angiogram of the same patient as in the previous 2 images shows a hypervascular intramural nodule that demonstrates a prolonged and intense enhancement with a surrounding avascular area, which represents the cyst surrounding the mural nodule. Note the stretching around the cyst.von Hippel-Lindau syndrome. Sagittal vertebral angvon Hippel-Lindau syndrome. Sagittal vertebral angiogram of the same patient as in the previous 3 images shows a hypervascular intramural nodule (open arrow) that demonstrates a prolonged and intense enhancement with a surrounding avascular area, representing the cyst surrounding the mural nodule (solid arrows). Note the stretching of vessels around the cyst. The final diagnosis was a cerebellar hemangioblastoma associated with von Hippel-Lindau syndrome (same patient as in Images 1-3).VHL is characterized by a predisposition to bilateral and multicentric retinal angiomas, central nervous system (CNS) hemangioblastomas; renal cell carcinomas; pheochromocytoma s; islet cell tumors of the pancreas; endolymphatic sac tumors[1] ; and renal, pancreatic, and epididymal cysts.[2, 3] CNS hemangioblastoma (Lindau tumor) is the most commonly recognized manifestation of VHL and occurs in 40% of patients.[4]

Symptoms often begin in the second to third decades of life. Patients may present with ocular signs and/or symptoms due to retinal hemorrhage, retinal detachment, glaucoma, or uveitis. Funduscopic examination may reveal tortuous aneurysms of the retinal vessels, exudates on the fundus, and subretinal yellowish spots. Patients may present with neurologic symptoms such as headaches, ataxia, and blindness. The exact neurologic deficit depends on the site of the primary lesion.

Magnetic Resonance Imaging

Hemangioblastomas occur throughout the CNS, but they have several favored locations, including the cerebellum (most common site), medulla, spinal cord, and retina. Although hemangioblastomas can occur as isolated tumors, retinal tumors are mostly confined to VHL.[13, 11, 12]

MRI appearances of a hemangioblastoma are those of a well-demarcated cystic lesion with a highly vascular mural nodule that abuts on the pia mater.

Appearances of the cystic component vary depending on the protein concentration and/or presence of hemorrhage within the cyst. The cystic component may be isointense relative to cerebrospinal fluid (CSF) on images obtained with all pulse sequences, but more often, it is slightly hyperintense relative to CSF on T1- and T2-weighted images.

Mural nodules are slightly hypointense on T1-weighted images and hyperintense on T2-weighted images, and they are avidly enhancing after the administration of contrast material.

Large feeding or draining vessels are often present at the periphery and within the solid component, and they may show tubular areas of flow void on spin-echo images.

Although the lesion is benign, it may resemble malignant lesions on advanced MR images. It may have elevated relative tumor blood volume on perfusion MR. Similarly, it may show elevated choline on MR spectroscopy.

Endolymphatic sac tumors are heterogeneous on both T1- and T2-weighted images. They are associated with focal high signal intensity on T1-weighted images due to subacute hemorrhage and with areas of low signal intensity due to calcification or hemosiderin.

Blood and protein-filled cysts have high signal intensity on both T1-weighted and T2-weighted images; a finding of these cysts may suggest the diagnosis.

Tumors larger than 2 cm may have flow voids.

After the administration of contrast material, the tumor enhances heterogeneously.

On MRIs, choroidal capillary hemangiomas associated with VHL are minimally hyperintense on T1-weighted images. They may mimic ocular melanoma, but unlike pigmented melanoma, they are usually hyperintense on T2-weighted images.

As a result of the small size of retinal hemangiomas (1.5-2.0 mm), they are usually not identified on MRIs.

Spinal hemangioblastomas are intramedullary tumors in most patients (75%), but they may be radicular (20%) or intradural extramedullary (5%). Most of these tumors are located in the cervicothoracic spine. They usually expand the cord and have an intratumoral cystic component. On MRIs, they appear as a well-demarcated gadolinium-enhancing mass. Spinal hemangioblastomas are an unusual cause of cryptic subarachnoid hemorrhage. Patients with subarachnoid hemorrhage with negative cerebral angiography may benefit from contrast-enhanced spinal MRI to rule out an occult spinal hemangioblastoma.

An intramural nodule that enhances intensely may be visible. Large dorsally placed draining veins may appear as curvilinear areas of signal void. A syrinx is a frequently associated finding.

A pheochromocytoma associated with VHL has MRI appearances no different from those of the sporadic form. The tumor appears isointense or slightly hypointense relative to the liver on T1-weighted images, and it is extremely hyperintense on T2-weighted images.

Magnetic resonance images of von Hippel-Lindau syndrome are depicted below.

von Hippel-Lindau syndrome. Coronal T1-weighted MRvon Hippel-Lindau syndrome. Coronal T1-weighted MRI shows an enhancing lesion in the right cerebellar hemisphere compressing and displacing the aqueduct and fourth ventricle to the left. Note the tubular areas of flow void resulting from large blood vessels and the cystic tumor component.von Hippel-Lindau syndrome. Coronal T1-weighted MRvon Hippel-Lindau syndrome. Coronal T1-weighted MRI (same patient as in the previous image) shows an enhancing lesion in the right cerebral hemisphere that compresses and displaces the aqueduct and fourth ventricle to the left. Note the tubular areas of flow void resulting from large blood vessels.von Hippel-Lindau syndrome. Oblique coronal T1-weivon Hippel-Lindau syndrome. Oblique coronal T1-weighted gadolinium-enhanced MRI through the right kidney shows a hypointense linear mass extending from the renal capsule to the renal pelvis. At surgery, a renal cell carcinoma was confirmed.von Hippel-Lindau syndrome. Coronal T1-weighted covon Hippel-Lindau syndrome. Coronal T1-weighted contrast enhanced MRI shows an intensely enhancing cerebellar lesion (red arrow) with a large cystic tumor component (white arrow).von Hippel-Lindau syndrome. Coronal T1-weighted covon Hippel-Lindau syndrome. Coronal T1-weighted contrast enhanced MRI (same patient as in the previous image) shows, at lower sections, an intensely enhancing cerebellar lesion with a large cystic tumor component. Note also the enhancing mural nodules and intratumoral flow void due to large pathological vessels.von Hippel-Lindau syndrome. Sagittal T2-weighted Mvon Hippel-Lindau syndrome. Sagittal T2-weighted MRI (same patient as in the previous 2 images) shows a cerebellar lesion with a large septate cystic component (arrow). Note the hydrocephalus.von Hippel-Lindau syndrome. Sagittal T2-weighted Mvon Hippel-Lindau syndrome. Sagittal T2-weighted MRI (same patient as in the previous 3 images) shows a cerebellar lesion with a central low signal component related to intratumoral hemorrhage.von Hippel-Lindau syndrome. Axial T2-weighted MRI von Hippel-Lindau syndrome. Axial T2-weighted MRI shows high signal nodules in the region of previous surgical resection of hemangioblastoma in an 18-month surveillance scan. An earlier scan showed no nodular lesions in this region. The appearance suggests a recurrence of hemangioma.von Hippel-Lindau syndrome. Axial T2-weighted MRI von Hippel-Lindau syndrome. Axial T2-weighted MRI (same patient as in the previous image) shows high signal nodules in the region of previous surgical resection of hemangioblastoma in an 18-month surveillance scan. An earlier scan showed no nodular lesions in this region. The appearance suggests a recurrence of hemangioma.

Gadolinium warning

Gadolinium-based contrast agents (gadopentetate dimeglumine [Magnevist], gadobenate dimeglumine [MultiHance], gadodiamide [Omniscan], gadoversetamide [OptiMARK], gadoteridol [ProHance]) have been linked to the development of nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy (NFD). The disease has occurred in patients with moderate to end-stage renal disease after being given a gadolinium-based contrast agent to enhance MRI or MRA scans.

Characteristics of NSF/NFD include red or dark patches on the skin; burning, itching, swelling, hardening, and tightening of the skin; yellow spots on the whites of the eyes; joint stiffness with trouble moving or straightening the arms, hands, legs, or feet; pain deep in the hip bones or ribs; and muscle weakness.

Degree of confidence

MRI is the modality of choice for imaging the central nervous system in patients in whom hemangioblastoma is suggested and for screening asymptomatic patients with VHL and their relatives at risk for VHL.

False positives/negatives

False-positive diagnoses may occur with cystic astrocytomas, which are usually smaller than 5 cm in diameter; these may be calcified, and they usually have thicker walls. Cystic metastases occasionally resemble a hemangioblastoma superficially. Spinal hemangioblastomas must be differentiated from intramedullary hemorrhage.

Endolymphatic sac tumors may mimic other cerebellopontine tumors. Nonfunctioning adrenal adenomas, adrenocortical adenomas, and adrenal cysts must be differentiated from pheochromocytomas associated with VHL.


Posted in Uncategorized.